Survival of ethnic and racial minority patients with multiple myeloma treated with newer medications
- PMID: 29365319
- PMCID: PMC5786427
- DOI: 10.1182/bloodadvances.2017010512
Survival of ethnic and racial minority patients with multiple myeloma treated with newer medications
Abstract
Patients of minority race with myeloma have had less increase in population-level survival in the early 21st century than white patients.
Data from clinical trials show that mortality is similar for minorities, suggesting the population-level difference is due to utilization.
Conflict of interest statement
Conflict-of-interest disclosure: The authors declare no competing financial interests.
References
-
- Kaya H, Peressini B, Jawed I, et al. Impact of age, race and decade of treatment on overall survival in a critical population analysis of 40,000 multiple myeloma patients. Int J Hematol. 2012;95(1):64-70. - PubMed
-
- Pulte D, Redaniel MT, Brenner H, Jeffreys M. Changes in survival by ethnicity of patients with cancer between 1992-1996 and 2002-2006: is the discrepancy decreasing? Ann Oncol. 2012;23(9):2428-2434. - PubMed
-
- Pulte D, Redaniel MT, Brenner H, Jansen L, Jeffreys M. Recent improvement in survival of patients with multiple myeloma: variation by ethnicity. Leuk Lymphoma. 2014;55(5):1083-1089. - PubMed
-
- Ailawadhi S, Aldoss IT, Yang D, et al. Outcome disparities in multiple myeloma: a SEER-based comparative analysis of ethnic subgroups. Br J Haematol. 2012;158(1):91-98. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
